BTG2 and brain neoplasm: On the molecular level, all three cell cycle arrest genes that were upregulated under combination therapy in our study (GADD45A, CDKN1A, and BTG2), where Cx43 function was inhibited, showed a positive correlation with GJA1 levels in brain tumor tissue.